Encompass Health elevates Patrick Tuer to COO role

BIRMINGHAM, Ala. - Encompass Health Corp. (NYSE: EHC), a leading provider of inpatient rehabilitation services with a market capitalization of $10.24 billion, has promoted Patrick Tuer to the role of chief operating officer (COO), effective immediately. In his new position, Tuer will oversee hospital operations for the company’s extensive network. According to InvestingPro data, the company maintains a "GREAT" financial health score, reflecting its strong operational foundation.

Tuer’s promotion comes as Encompass Health continues to expand, with a focus on its de novo program and capacity enhancements at existing hospitals. The company has demonstrated robust growth, with revenue increasing by 11.91% over the last twelve months. Mark Tarr, president and CEO of Encompass Health, expressed confidence in Tuer’s abilities, citing his significant contributions to the company’s operational success and growth in several regions.

As the former group president, Tuer managed operations across three geographic regions, encompassing a total of 69 hospitals. His tenure at Encompass Health began in 2018, and he has since held multiple leadership roles, including regional president and regional vice president. Tuer’s experience prior to Encompass Health involved leadership positions in both acute and post-acute hospital organizations.

Tuer expressed his readiness to take on the COO role, highlighting the company’s strong platform and dedicated workforce. He emphasized the importance of strategic growth, innovation, and delivering high-quality care to patients and communities.

Encompass Health operates 167 hospitals in 38 states and Puerto Rico, making it the largest owner and operator of inpatient rehabilitation hospitals in the U.S. The company is recognized for its commitment to high-quality, compassionate care, and has received accolades from Fortune and Becker’s Hospital Review, as well as being listed among Forbes’ Most Trusted Companies in America. The company’s stock is currently trading near its 52-week high, with a strong return on equity of 25%. For deeper insights into Encompass Health’s performance metrics and growth potential, investors can access comprehensive analysis through InvestingPro’s detailed research reports.

This announcement is based on a press release statement from Encompass Health. The company has not only emphasized its robust development pipeline but also cautioned that forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations. Notable among its achievements is a 13-year track record of consistent dividend payments, demonstrating strong financial stability and commitment to shareholder returns.

The promotion of Tuer to COO reflects Encompass Health’s strategy to strengthen its leadership team in support of its growth trajectory and commitment to enhancing patient care across its facilities.

In other recent news, Encompass Health Corporation reported its first-quarter earnings, with Raymond James adjusting its EBITDA estimate to $285 million, slightly down from the initial $290.6 million projection. This adjustment reflects typical first-quarter seasonality and increased labor costs. Despite the revision, Raymond James maintains a Strong Buy rating with a price target of $120, citing the company’s durable growth trends. KeyBanc Capital Markets also raised its price target for Encompass Health to $120, highlighting the company’s impressive fourth-quarter performance and robust growth strategy. Encompass Health’s fourth-quarter EBITDA exceeded expectations by 7%, with a year-over-year growth of 14%, attributed to strong same-store volumes and margin performance. Additionally, the company declared a quarterly cash dividend of $0.17 per share, payable on April 15, 2025, continuing its commitment to returning value to shareholders. In executive news, Encompass Health announced increased compensation for its executives, including a salary and bonus boost for CEO Mark Tarr. The changes align executive pay with performance and market standards. These developments underscore Encompass Health’s strategic focus on growth and shareholder value.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.